Inkwood Research estimates that the global dermatological therapeutics market will project a CAGR of 7.54% during the forecast period & will reach revenue of $ 49.81 billion by 2028. The base year considered for the market study is 2018, while the forecasted period is between 2019 and 2028. The market is majorly driven by the rising burden of dermatology diseases. Skin disease is one of the principal causes of the growing disease burden that affects millions of people, across the globe.
GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028
Global Dermatological Therapeutics Market by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other Drug Classes) by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Acne Vulgaris, Other Applications) and by Geography.
Inkwood Research estimates that the global dermatological therapeutics market will project a CAGR of 7.54% during the forecast period & will reach revenue of $ 49.81 billion by 2028. The base year considered for the market study is 2018, while the forecasted period is between 2019 and 2028.
The global dermatological therapeutics market growth is propelled by:
- Rising load of dermatology diseases
- Rise in awareness levels of disease progression and origin
To know more about this report, request a free sample copy
The market is majorly driven by the rising burden of dermatology diseases. Skin disease is one of the principal causes of the growing disease burden that affects millions of people, across the globe. The factors responsible for the development of an adverse number of skin diseases include aging, environmental, and genetic. According to the statistics provided by the Centre for Disease Control and Prevention (CDC), during the year 2018, around 14.3% of the children aged between 0 to 4 years’ had skin allergies. CDC has stated that the number of children having skin allergy is increasing each year, which can be the fueling factor for the market studied. Moreover, according to the Global Burden of Disease (GBD), skin diseases remain to be the important cause of nonfatal disease burden globally, thereby fueling market demand.
Psoriasis was the dominating application segment in terms of revenue in 2019, with a market share of 36.02%. Psoriasis is a prolonged autoimmune disease that rapidly speeds up the development of skin cells. It causes blotches of red skin and scales on the face, knees, scalp, and feet. Globally, 125 million people suffer from psoriasis as per the National Psoriasis Foundation’s 2019 report. In the United States, more than 8 million people suffer from psoriasis.
On the other hand, Atopic Dermatitis is anticipated to be the leading application segment, projecting a CAGR of around 8.65% by the end of the forecast period. As per the Global Burden of Disease/Institute for Health Metrics and Evaluation, in 2017, approximately 3.19% of the Italian population was affected by atopic dermatitis.
However, the side effects caused by several therapeutics are restraining market growth. Some of the products are withdrawn from the market due to serious side effects. For example, Genentech Inc, in 2010, voluntarily announced the withdrawal of its psoriasis drug Aptiva from the market after it was linked with the fatal brain disorder.
The report scope of the global dermatological therapeutics market covers the segmentation analysis of drug class and application.
Market by Drug Class:
- Anti-infectives
- Corticosteroids
- Anti-acne
- Calcineurin Inhibitors
- Retinoids
- Other Drug Classes
Market by Application:
- Psoriasis
- Herpes
- Alopecia
- Acne Vulgaris
- Atopic Dermatitis
- Rosacea
- Other Applications
On the basis of geography, the global dermatological therapeutics market has been segmented into four major regions:
- North America: the United States and Canada
- Europe: the United Kingdom, France, Germany, Italy, Russia, Belgium, Poland, and Rest of Europe
- Asia Pacific: China, Japan, India, South Korea, Thailand, Indonesia, Vietnam, Australia & New Zealand, and Rest of Asia Pacific
- Rest of World: Latin America, the Middle East & Africa
Geographically, the region of North America held the largest market share of 40.02%, in terms of revenue, in 2019. North America is the principal market, as a result of the increasing rate of pores and skin diseases and increasing concentration of dermatology cases inside the zones. The U.S. is the greatest profitable center for dermatology drugs, thereby fueling market demand in the region.
On the other hand, the Asia Pacific is set to be the fastest-growing region with a CAGR of 7.96%, during the forecast period. In the Asia Pacific, the accumulative group of the consumer population, increasing awareness, and growing disposable incomes are expected to be pivotal to the robust market growth in the region. Furthermore, the Japanese population is aging faster than the other regions. The Health and Welfare Ministry estimated that the 65+ age group will account for 40% of the population by 2060. Therefore, the cumulative geriatric population requires services regularly, and hence, is a good consumer base for dermatological treatments.
The key players involved in global dermatological therapeutics market are:
- AbbVie Inc
- Amgen Inc
- Galderma
- Others
In February 2020, Almirall announced a partnership to boost digital innovation in dermatology. Almirall will enter into the Plug and Play Health program so as to gain access to the largest health innovation ecosystem globally, which includes stakeholders and startups.
Key trends of the global dermatological therapeutics market are:
- North America dominated the global dermatological therapeutics market in 2019.
- The Asia Pacific region is set to be the fastest-growing region by 2028.
- The increasing strategic partnerships among key players are driving the overall market growth.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
- RISING LOAD OF DERMATOLOGY DISEASES
- RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
- KEY RESTRAINTS
- SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
- KEY ANALYTICS
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- BUYER POWER
- SUPPLIER POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY DRUG CLASS
- ANTI-INFECTIVES
- CORTICOSTEROIDS
- ANTI-ACNE
- CALCINEURIN INHIBITORS
- RETINOIDS
- OTHER DRUG CLASSES
- MARKET BY APPLICATION
- ALOPECIA
- HERPES
- PSORIASIS
- ROSACEA
- ATOPIC DERMATITIS
- ACNE VULGARIS
- OTHER APPLICATIONS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- EUROPE
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- ASIA PACIFIC
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA PACIFIC
- REST OF WORLD
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
- COMPANY PROFILES
- ABBVIE INC
- ALLERGAN INC
- ALMIRAL
- AMGEN INC
- BAUSCH HEALTH COMPANIES INC
- GALDERMA
- GLAXOSMITHKLINE PLC
- JOHNSON & JOHNSON
- NOVARTIS AG
- PFIZER INC
- AGI DERMATICS
- LEO PHARMA A/S
- MERCK KGAA
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – DERMATOLOGICAL THERAPEUTICS
TABLE 2: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 3: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 4: GLOBAL ANTI-INFECTIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 5: GLOBAL ANTI-INFECTIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 6: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 7: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 8: GLOBAL ANTI-ACNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN BILLION)
TABLE 9: GLOBAL ANTI-ACNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 10: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 11: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 12: GLOBAL RETINOIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 13: GLOBAL RETINOIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 14: GLOBAL OTHER DRUG CLASSES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 15: GLOBAL OTHER DRUG CLASSES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 16: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 17: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 18: GLOBAL ALOPECIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 19: GLOBAL ALOPECIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 20: GLOBAL HERPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 21: GLOBAL HERPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 22: GLOBAL PSORIASIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 23: GLOBAL PSORIASIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 24: GLOBAL ROSACEA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 25: GLOBAL ROSACEA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 26: GLOBAL ATOPIC DERMATITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 27: GLOBAL ATOPIC DERMATITIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 28: GLOBAL ACNE VULGARIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 29: GLOBAL ACNE VULGARIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 30: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 31: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 32: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 33: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 34: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 35: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 36: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 37: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 38: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 39: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 40: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 41: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2019-2028 (IN $ BILLION)
LIST OF FIGURES
FIGURE 1: KEY INVESTMENT INSIGHTS
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUG CLASS, IN 2019
FIGURE 6: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)
FIGURE 7: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)
FIGURE 8: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)
FIGURE 9: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)
FIGURE 10: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)
FIGURE 11: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)
FIGURE 12: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
FIGURE 13: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)
FIGURE 14: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)
FIGURE 15: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)
FIGURE 16: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)
FIGURE 17: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)
FIGURE 18: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)
FIGURE 19: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)
FIGURE 20: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 21: UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 22: CANADA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 23: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 24: UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 25: GERMANY DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 26: FRANCE DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 27: ITALY DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 28: RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 29: BELGIUM DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 30: POLAND DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 31: REST OF EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 32: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 33: CHINA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 34: JAPAN DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 35: INDIA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 36: SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 37: INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 38: THAILAND DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 39: VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 40: AUSTRALIA & NEW ZEALAND DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 41: REST OF ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 42: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 43: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
FIGURE 44: MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)
- MARKET BY DRUG CLASS
- ANTI-INFECTIVES
- CORTICOSTEROIDS
- ANTI-ACNE
- CALCINEURIN INHIBITORS
- RETINOIDS
- OTHER DRUG CLASSES
- MARKET BY APPLICATION
- ALOPECIA
- HERPES
- PSORIASIS
- ROSACEA
- ATOPIC DERMATITIS
- ACNE VULGARIS
- OTHER APPLICATIONS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- EUROPE
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- ASIA PACIFIC
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA PACIFIC
- REST OF WORLD
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.